J&J asks court for quick decision in 340B rebate model fightnews2025-02-04T20:48:04+00:00February 4th, 2025|Endpoints News|
Pfizer says it has at least $10B available for deals in 2025news2025-02-04T20:40:32+00:00February 4th, 2025|Endpoints News|
Merck CEO says he’s confident in growth despite Gardasil ‘headwind’news2025-02-04T19:41:34+00:00February 4th, 2025|Endpoints News|
Illumina added to China’s blacklist following Biosecure Act, tariffsnews2025-02-04T17:00:18+00:00February 4th, 2025|Endpoints News|
FDA approves Supernus’ Parkinson’s drug-device after two rejectionsnews2025-02-04T15:21:50+00:00February 4th, 2025|Endpoints News|
Bavarian Nordic’s stock sinks after 2024 revenues underwhelmnews2025-02-04T14:00:08+00:00February 4th, 2025|Endpoints News|
Updated: Pfizer sticks to 2025 projections as Covid sales stabilize, R&D revamp continuesnews2025-02-04T12:52:07+00:00February 4th, 2025|Endpoints News|
Regeneron will start delivering quarterly dividends 37 years into its existencenews2025-02-04T12:20:19+00:00February 4th, 2025|Endpoints News|
Astellas shakes up management despite impressive nine-month earningsnews2025-02-04T11:49:56+00:00February 4th, 2025|Endpoints News|
Merck pauses Gardasil shipments to Chinanews2025-02-04T11:30:48+00:00February 4th, 2025|Endpoints News|
